Key result
Intravenous ethinyl estradiol acutely attenuated abnormal coronary vasomotor responses to acetylcholine and increased basal coronary flow by 23.3% (P<0.01) in postmenopausal women.
Why the study?
Does intravenous ethinyl estradiol improve abnormal coronary vasomotor responses to acetylcholine in postmenopausal women?
Population
33 postmenopausal women
Comparison
Ethinyl estradiol administered intravenously vs Placebo and baseline measurements
Follow-up
15 minutes
Authors
Loading...
Supports vasomotor mechanism for estrogen cardioprotection in postmenopausal women; leaves open need for outcome trials.
RCT (n=48)
Does intravenous ethinyl estradiol improve abnormal coronary vasomotor responses to acetylcholine in postmenopausal women?
p-value: p=<0.01
Acute administration of ethinyl estradiol attenuates abnormal coronary vasomotor responses to acetylcholine and decreases basal coronary vasomotor tone in postmenopausal women, suggesting a mechanism for its cardioprotective effects.
Reís et al. (1994) conducted an RCT in Postmenopausal women (n=48). Ethinyl estradiol vs. Placebo was evaluated on Acetylcholine-induced changes in coronary flow, resistance, and cross-sectional area (p=<0.01). Intravenous ethinyl estradiol acutely attenuated abnormal coronary vasomotor responses to acetylcholine and increased basal coronary flow by 23.3% (P<0.01) in postmenopausal women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: